Runben Biotechnology Co Ltd Ordinary Shares - Class A
Runben Biotechnology Co., Ltd. engages in the research, production, and sale of mosquito repellent products, baby care products, and essential oil products. The company sells its products through online channels. Runben Biotechnology Co., Ltd. was founded in 1993 and is based in Guangzhou, China.Runben Biotechnology Co., Ltd. operates as a subsidiary of Guangzhou Zhuofan Investment Holding Co., L… Read more
Runben Biotechnology Co Ltd Ordinary Shares - Class A (603193) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.042x
Based on the latest financial reports, Runben Biotechnology Co Ltd Ordinary Shares - Class A (603193) has a cash flow conversion efficiency ratio of 0.042x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥91.93 Million) by net assets (CN¥2.17 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Runben Biotechnology Co Ltd Ordinary Shares - Class A - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Runben Biotechnology Co Ltd Ordinary Shares - Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Runben Biotechnology Co Ltd Ordinary Shares - Class A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Runben Biotechnology Co Ltd Ordinary Shares - Class A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Manorama Industries Limited
NSE:MANORAMA
|
0.013x |
|
Circassia Group Plc
OTCGREY:CSSPF
|
0.015x |
|
NIIT LEARNING SYSTEMS LTD
NSE:NIITMTS
|
N/A |
|
NHN KCP Corp
KQ:060250
|
0.120x |
|
338840
KQ:338840
|
-0.091x |
|
Tristel PLC
PINK:TSNLF
|
0.161x |
|
ADVA Optical Networking SE
PINK:ADVOF
|
0.047x |
|
389650
KQ:389650
|
0.000x |
Annual Cash Flow Conversion Efficiency for Runben Biotechnology Co Ltd Ordinary Shares - Class A (2019–2024)
The table below shows the annual cash flow conversion efficiency of Runben Biotechnology Co Ltd Ordinary Shares - Class A from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.08 Billion | CN¥257.24 Million | 0.124x | -5.93% |
| 2023-12-31 | CN¥1.92 Billion | CN¥252.52 Million | 0.131x | -42.55% |
| 2022-12-31 | CN¥722.59 Million | CN¥165.32 Million | 0.229x | -7.32% |
| 2021-12-31 | CN¥561.65 Million | CN¥138.65 Million | 0.247x | -29.13% |
| 2020-12-31 | CN¥250.14 Million | CN¥87.14 Million | 0.348x | -22.71% |
| 2019-12-31 | CN¥137.36 Million | CN¥61.91 Million | 0.451x | -- |